Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Performer
12308.0000 63.00 (0.51%)
NSE Jun 23, 2025 15:31 PM
Volume: 33,421
 

12308.00
0.51%
HDFC Securities
Maintain BUY with a TP of Rs 914 (16x FY20E EPS) Neuland Labs (NLL) delivered poor performance in its 1QFY19 results. Revenue grew 31%YoY to Rs 1.54bn (down 4%QoQ) and EBITDA at Rs 90mn was up 11.3%YoY (sequential drop of 52%) with margin at 5.8% (declining by ~100bpsYoY). PAT reduced by 37%YoY and 95%QoQ, standing at Rs 4.1mn.
Number of MF schemes increased from 16 to 23 in Mar 2025 qtr.
More from Neuland Laboratories Ltd.
Recommended